Newest first
New topics page 2
Topics ordered by when they were created rather than by activity. This is where a question that nobody has answered yet is easiest to find — and answering one is the fastest route to a first solution badge.
1,535 topics · page 2 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Prior authorisation: what the criteria usually require — a second dataset
Posting this under the heading it deserves: Prior authorisation: what the criteria usually require — a second dataset Everything below is what sits behind that. A coverage question with the paperwork detail…
|
+67 | 74 | 19k | 21h |
|
[2026 update] Documenting an adverse event properly
Documenting an adverse event properly Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published trials in this…
|
+18 | 22 | 4.3k | 1d |
|
Cleaning a self-reported dataset and what you throw away — what changed since
Posting this under the heading it deserves: Cleaning a self-reported dataset and what you throw away — what changed since Everything below is what sits behind that. Posting the method first, because I know…
|
2 | 2k | 1h | |
|
How much context is too much context in a first post?
How much context is too much context in a first post? I have a specific reason for asking rather than idle curiosity, and the context is below. Question in the title. Context below, and I have tried to…
|
+70 | 74 | 935 | 18d |
|
What is genuinely unknown about long-term amylin agonism
What is genuinely unknown about long-term amylin agonism — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing STEP 8 ( JAMA , 2022) with SURMOUNT-1 ( N Engl J Med…
|
+83 | 91 | 46k | 1d |
|
Evidence quality in the secretagogue literature: an honest assessment
Evidence quality in the secretagogue literature: an honest assessment Writing it up because I had to work it out twice and would rather nobody else did. Comparing SURMOUNT-OSA ( N Engl J Med , 2024) with STEP…
|
2 | 25k | 9d | |
|
What to bring: records that a clinician can actually use — a second dataset
What to bring: records that a clinician can actually use — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. Asking about a population rather than…
|
+80 | 86 | 5.6k | 3h |
|
Deletion sequences: expected mass shifts by residue — the long version
On the subject in the title: Deletion sequences: expected mass shifts by residue — the long version Working notes rather than a conclusion. Working through the identity arithmetic and I would like it checked.…
|
+21 | 25 | 6.9k | 10h |
|
Common supplements people ask about, assessed one at a time
Common supplements people ask about, assessed one at a time — setting out what I have, and where I think it stops being reliable. A question about technique rather than about dose. I have been doing the same…
|
+101 | 107 | 28k | 12h |
|
Coming back to: Batch date after test date, and other internal inconsistencies
On the subject in the title: Batch date after test date, and other internal inconsistencies Working notes rather than a conclusion. I would like to understand what this number means before I repeat it…
|
+21 | 27 | 420 | 3h |
|
[2026 update] Antibiotics and a course of something with delayed emptying
On the subject in the title: Antibiotics and a course of something with delayed emptying Working notes rather than a conclusion. Reporting something rather than asking about it, in case the pattern is useful…
|
+88 | 97 | 19k | 13h |
|
Reading order for a first week here, and what to skip until later — what changed since
Reading order for a first week here, and what to skip until later — what changed since Writing it up because I had to work it out twice and would rather nobody else did. I want to check my reasoning rather…
|
+89 | 93 | 28k | 4h |
|
BPC-157: what the rodent literature actually shows, and what it does not — does this still hold?
The question in the title: BPC-157: what the rodent literature actually shows, and what it does not — does this still hold? I will give what I have already checked below so nobody repeats it. I have seen…
|
+6 | 10 | 3.1k | 1d |
|
Coming back to: Telehealth prescribing models in the US
Posting this under the heading it deserves: Telehealth prescribing models in the US Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category…
|
+26 | 30 | 17k | 17h |
|
Immortal time bias in a claims-database study — one year on
Posting this under the heading it deserves: Immortal time bias in a claims-database study — one year on Everything below is what sits behind that. Comparing SURPASS-2 ( N Engl J Med , 2021) with SURMOUNT-1 (…
|
+41 | 46 | 3.7k | 22h |
|
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree
Detection wavelength and why 214 nm and 280 nm disagree — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know what the first three replies will…
|
+69 | 76 | 920 | 6h |
|
Journal club: SUSTAIN 6 and its retinopathy signal
On the subject in the title: Journal club: SUSTAIN 6 and its retinopathy signal Working notes rather than a conclusion. I have seen SELECT ( N Engl J Med , 2023) cited in support of a claim I do not think it…
|
+110 | 122 | 46k | 1d |
|
How shortages have affected compounding permissions
How shortages have affected compounding permissions I have a specific reason for asking rather than idle curiosity, and the context is below. A coverage question with the paperwork detail included, since that…
|
+61 | 71 | 3.6k | 2d |
|
Selection into a registry and what it does to the estimate — a second dataset
Posting this under the heading it deserves: Selection into a registry and what it does to the estimate — a second dataset Everything below is what sits behind that. Session topic: SURMOUNT-4 ( JAMA , 2024).…
|
+28 | 32 | 1.3k | 1d |
|
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people admit
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people admit Writing it up because I had to work it out twice and would rather nobody else did. Comparing SURPASS-4 ( Lancet ,…
|
+50 | 55 | 7.8k | 2d |
|
Journal club: STEP 1 and the treatment-policy estimand
Journal club: STEP 1 and the treatment-policy estimand Writing it up because I had to work it out twice and would rather nobody else did. Comparing SUSTAIN 6 ( N Engl J Med , 2016) with STEP 8 ( JAMA , 2022)…
|
3 | 11k | 9h | |
|
Coming back to: Where the four-week escalation interval comes from, and what it is not
Posting this under the heading it deserves: Where the four-week escalation interval comes from, and what it is not Everything below is what sits behind that. I have read the maintained page on this and I…
|
+44 | 48 | 11k | 1d |
|
Restarting after a long gap: what the labelling implies
Posting this under the heading it deserves: Restarting after a long gap: what the labelling implies Everything below is what sits behind that. I have read the maintained page on this and I still have a gap,…
|
+41 | 46 | 11k | 15h |
|
What a reversed-phase purity number actually is
The question in the title: What a reversed-phase purity number actually is I will give what I have already checked below so nobody repeats it. I would like to understand what this number means before I repeat…
|
+87 | 101 | 27k | 4h |
|
Second pass at: Orforglipron as a non-peptide: what changes when the molecule is small
Second pass at: Orforglipron as a non-peptide: what changes when the molecule is small Writing it up because I had to work it out twice and would rather nobody else did. Comparing SURPASS-4 ( Lancet , 2021)…
|
2 | 17k | 6h | |
|
Why I now write the concentration on the vial in marker
Asking directly, because I could not find a straight answer: Why I now write the concentration on the vial in marker Practical question with the units stated, because I have seen how quickly these go wrong…
|
+1 | 5 | 30k | 11d |
|
What a regulator's shortage notice actually authorises
What a regulator's shortage notice actually authorises — that is the question, and I have not found it answered plainly anywhere I have looked. A logistics question, since the answers here are usually better…
|
+8 | 12 | 15k | 17h |
|
Sleep quality changes during weight loss
On the subject in the title: Sleep quality changes during weight loss Working notes rather than a conclusion. Asking about a population rather than about a person. The published trials in this class mostly…
|
+27 | 31 | 555 | 5h |
|
Athletes in weight-category sports: a different risk calculus
Athletes in weight-category sports: a different risk calculus — setting out what I have, and where I think it stops being reliable. General question, not a request for advice about my own care — I know the…
|
+38 | 42 | 6.6k | 1d |
|
Revisiting: Protein density versus volume when you cannot eat much
Revisiting: Protein density versus volume when you cannot eat much Writing it up because I had to work it out twice and would rather nobody else did. Longitudinal report with the method stated, because a…
|
+97 | 108 | 3.6k | 2d |